Sofiva Genomics Co.,Ltd. (TPEX:6615)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.95
+0.35 (1.04%)
At close: Apr 24, 2026
Market Cap733.10M -15.5%
Revenue (ttm)385.71M -14.9%
Net Income-9.36M
EPS-0.43
Shares Out21.59M
PE Ration/a
Forward PEn/a
Dividend0.30 (0.89%)
Ex-Dividend DateJun 27, 2025
Volume14,304
Average Volume29,959
Open33.90
Previous Close33.60
Day's Range33.70 - 33.95
52-Week Range28.90 - 37.05
Beta0.27
RSI50.56
Earnings DateMay 15, 2026

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessm... [Read more]

Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6615
Full Company Profile

Financial Performance

Financial Statements